A detailed history of Mesirow Financial Investment Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 8,500 shares of HALO stock, worth $485,775. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,500
Previous 8,500 -0.0%
Holding current value
$485,775
Previous $445,000 9.21%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$37.81 - $52.4 $321,385 - $445,400
8,500 New
8,500 $445,000
Q1 2024

Apr 25, 2024

BUY
$33.68 - $41.95 $286,280 - $356,575
8,500 New
8,500 $345,000
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $266,560 - $336,800
8,000 New
8,000 $295,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.96B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.